To buy shares listed in Australia such as CSL, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
| 52-week range | $227.1877 - $308.683 |
|---|---|
| 50-day moving average | $283.9422 |
| 200-day moving average | $270.5668 |
| Target price | $305.21 |
| PE ratio | 34.4652 |
| Dividend yield | $2.48 (1.4%) |
| Earnings per share (TTM) | $7.91 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$275.47
| 1 week (2024-04-16) | 0.28% |
|---|---|
| 1 month (2024-03-22) | -1.95% |
| 3 months (2024-01-24) | -5.47% |
| 6 months (2023-10-24) | 16.11% |
| 1 year (2023-04-24) | -9.49% |
|---|---|
| 2 years (2022-04-22) | 1.70% |
| 3 years (2021-04-23) | 0.78% |
| 5 years (2019-04-24) | 41.27% |
Valuing CSL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CSL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CSL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, CSL shares trade at around 34x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CSL's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.4 billion (£2.3 billion).
The EBITDA is a measure of a CSL's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $14.2 billion |
|---|---|
| Operating margin TTM | 32.45% |
| Gross profit TTM | $6.8 billion |
| Return on assets TTM | 6.41% |
| Return on equity TTM | 13.63% |
| Profit margin | 17.43% |
| Book value | 35.556 |
| Market capitalisation | $132.7 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CSL.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 27.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CSL's overall score of 27.73 (as at 12/31/2018) is pretty good – landing it in it in the 40th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CSL is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.04/100
CSL's environmental score of 3.04 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.57/100
CSL's social score of 18.57 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 11.12/100
CSL's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CSL is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CSL scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that CSL has, for the most part, managed to keep its nose clean.
CSL Ltd was last rated for ESG on: 2019-01-01.
| Total ESG score | 27.73 |
|---|---|
| Total ESG percentile | 39.7 |
| Environmental score | 3.04 |
| Environmental score percentile | 5 |
| Social score | 18.57 |
| Social score percentile | 5 |
| Governance score | 11.12 |
| Governance score percentile | 5 |
| Level of controversy | 2 |
Dividend payout ratio: 46.74% of net profits
Recently CSL has paid out, on average, around 46.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CSL shareholders could enjoy a 1.4% return on their shares, in the form of dividend payments. In CSL's case, that would currently equate to about A$2.48 per share.
While CSL's payout ratio might seem fairly standard, it's worth remembering that CSL may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 10 March 2024 (the "ex-dividend date").
CSL's shares were split on a 3:1 basis on 17 October 2007. So if you had owned 1 share the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your CSL shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for CSL shares which in turn could have impacted CSL's share price.
Over the last 12 months, CSL's shares have ranged in value from as little as $227.1877 up to $308.683. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while CSL's is 0.29. This would suggest that CSL's shares are less volatile than average (for this exchange).
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
ANZ Group Holdings Ltd. Pfd.
AUD101.63
Challenger Ltd Preferred
AUD105.11
Macquarie Bank Ltd Pref
AUD106.32
Macquarie Group Ltd Pref C
AUD102.93
Macquarie Group Ltd Pref
AUD105.63
Macquarie Group Limited
AUD105.95
Suncorp Group Ltd Pref
AUD100.61
Westpac Banking Corp Pref
AUD102.80
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Blinklab shares.
Everything we know about the Maverick Minerals IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a flat $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?